ストックスクリーナーアプリを入手
0.866
2.48%
-0.022
アフターアワーズ：
.89
0.024
+2.77%
前日終値:
$0.888
開ける：
$0.8896
24時間の取引高:
3.61M
Relative Volume:
0.34
時価総額：
$84.86M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-10.31%
1か月 パフォーマンス:
+20.04%
6か月 パフォーマンス:
-75.04%
1年 パフォーマンス:
-72.24%
1日の値動き範囲:
$0.866
$0.9239
1週間の範囲:
$0.866
$1.02
52週間の値動き範囲:
$0.6816
$7.2904
Atyr Pharma Inc Stock (ATYR) Company Profile
名前
Atyr Pharma Inc
セクター
電話
(858) 731-8389
住所
10240 SORRENTO VALLEY ROAD, SAN DIEGO
ATYR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATYR
Atyr Pharma Inc
|
0.866 | 87.01M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-16 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-09-15 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-09-15 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-09-15 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-09-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-18 | 開始されました | Leerink Partners | Outperform |
| 2025-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-10-04 | 開始されました | Wells Fargo | Overweight |
| 2024-09-05 | 開始されました | Jefferies | Buy |
| 2023-07-05 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-10-12 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-09-21 | 開始されました | Piper Sandler | Overweight |
| 2021-05-10 | 開始されました | Laidlaw | Buy |
| 2020-08-17 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | 開始されました | ROTH Capital | Buy |
| 2020-03-02 | 開始されました | Oppenheimer | Outperform |
| 2018-02-14 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-09-07 | 開始されました | Piper Jaffray | Overweight |
| 2016-12-13 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2015-12-16 | 開始されました | Citigroup | Neutral |
| 2015-06-01 | 開始されました | Citigroup | Buy |
| 2015-06-01 | 開始されました | JP Morgan | Overweight |
すべてを表示
Atyr Pharma Inc (ATYR) 最新ニュース
Class Action Lawsuit Filed: aTyr Pharma, Inc. (ATYR)Join by December 8, 2025Contact Levi & Korsinsky - Stockhouse
ATYR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - Newsfile
Is aTyr Pharma Inc. stock cheap at current valuation2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
What catalysts could drive aTyr Pharma Inc. stock higherMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com
Real time breakdown of aTyr Pharma Inc. stock performance2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Is aTyr Pharma Inc. stock poised for growthGDP Growth & Weekly Market Pulse Alerts - newser.com
aTyr Pharma Inc. stock prediction for this weekGDP Growth & Verified High Yield Trade Plans - newser.com
Lost Money on aTyr Pharma, Inc. (ATYR)? Contact Levi & Korsinsky to Join Class Action Before December 8, 2025 - ACCESS Newswire
December 8, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ATYR - Bluefield Daily Telegraph
Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) InvestorsLead Plaintiff Deadline on December 8, 2025 - Stockhouse
ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) - GlobeNewswire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - Newsfile
aTyr Pharma (ATYR) to Release Earnings on Thursday - MarketBeat
What earnings revisions data tells us about aTyr Pharma Inc.July 2025 Breakouts & Fast Entry Momentum Alerts - newser.com
Will aTyr Pharma Inc. (471A) stock outperform benchmarksInsider Selling & Weekly Chart Analysis and Guides - newser.com
How aTyr Pharma Inc. (471A) stock reacts to stronger dollarPortfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, - GlobeNewswire
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming ... - Caledonian Record
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ATYR - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming DeadlinesATYR - FinancialContent
Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors - GlobeNewswire
ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged — Hagens Berman - Morningstar
Why aTyr Pharma Inc. stock could see breakout soonWeekly Investment Report & Entry Point Confirmation Signals - newser.com
Ranking aTyr Pharma Inc. among high performing stocks via toolsJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is aTyr Pharma Inc. stock a defensive play in 2025Weekly Trend Summary & Comprehensive Market Scan Insights - newser.com
Burned by aTyr Pharma, Inc.? Contact Levi & Korsinsky to SueWallSt and Fight Back - ACCESS Newswire
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Does aTyr Pharma Inc. show high probability of reboundPortfolio Gains Summary & Advanced Technical Analysis Signals - newser.com
Lawsuit filed for Investors who lost money with shares of aTyr Pharma, Inc. (NASDAQ: ATYR) - openPR.com
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportu - GuruFocus
Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about ... - Bluefield Daily Telegraph
Investors who lost money on aTyr Pharma, Inc.(ATYR) should - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - MarketScreener
Statistical indicators supporting aTyr Pharma Inc.’s strengthProfit Target & Fast Moving Trade Plans - newser.com
Will aTyr Pharma Inc. stock go up soonRate Cut & Verified Momentum Watchlists - newser.com
How aTyr Pharma Inc. stock responds to policy changesJuly 2025 Closing Moves & Weekly Market Pulse Updates - fcp.pa.gov.br
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr ... - Black Hills Pioneer
Will aTyr Pharma Inc. stock benefit from upcoming earnings reports2025 Market Overview & Fast Gain Stock Trading Tips - fcp.pa.gov.br
Relative strength of aTyr Pharma Inc. in sector analysisAnalyst Upgrade & Verified Entry Point Signals - newser.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Class Action Reminder: ATYR Investors Should Contact Robbins LLP for Information About Leading the aTyr Pharma, Inc. Class Action Lawsuit - Morningstar
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, - GlobeNewswire
ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) - GlobeNewswire
Atyr Pharma Inc (ATYR) 財務データ
Atyr Pharma Inc (ATYR) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):